Molecular Medicine Reports

Prevention and modulation of aminoglycoside ototoxicity (Review)
pp. 3-13(11)
Authors: Perletti; Vral; Patrosso; Marras; Ceriani; Willems; Fasano; Magri

Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcome? (Review)
pp. 15-20(6)
Author: Zhu

Colonic serrated pathway lesions: Molecular and histologic changes in serrated colonic proliferations (Review)
pp. 21-26(6)
Authors: Fogt, Franz; Rahemtulla, Amir; Jian, Bo

p16, cyclin D1 and Rb expression in colorectal carcinomas: Correlations with clinico-pathological parameters and prognosis
pp. 27-32(6)
Authors: Von Stockmar-Von Wangenheim; Mönig; Schneider; Landsberg; Drebber; Hölscher; Dienes; Baldus

Disruption of the IQSEC2 transcript in a female with X;autosome translocation t(X;20)(p11.2;q11.2) and a phenotype resembling X-linked infantile spasms (ISSX) syndrome
pp. 33-39(7)
Authors: Morleo, Manuela; Iaconis, Daniela; Chitayat, David; Peluso, Ivana; Marzella, Rosalia; Renieri, Alessandra; Mari, Francesca; Franco, Brunella

Benefit from a high dose of gefitinib in a woman with lung adenocarcinoma and an epidermal growth factor receptor tyrosine-kinase acquired mutation
pp. 41-43(3)
Authors: Baldini, Editta; Prochilo, Tiziana; Boldrini, Laura; Melfi, Franca; Fontanini, Gabriella

Two allele-specific PCR assays for screening epidermal growth factor receptor gene hotspot mutations in lung adenocarcinoma
pp. 45-50(6)
Authors: Dahse, Regine; Berndt, Alexander; Dahse, Anne-Kristin; Kosmehl, Hartwig

Proteomic analysis of mucosal preparations from patients with ulcerative colitis
pp. 51-54(4)
Authors: Fogt; Jian; Krieg; Wellmann

A low level of nicotine-induced chemoresistance in a KB cell line
pp. 55-60(6)
Authors: Do, Nam-Yong; Lim, Sung-Chul

SOCS1 silencing can break high-dose dendritic cell immunotherapy-induced immune tolerance
pp. 61-70(10)
Authors: Hu; Qin; Qian; Jiang; Li; Jiang; Li; Chen; Zang

Relationship between the signal ratios of HER-2/CEP17 and c-MYC/CEP17 and the pathological response of neoadjuvant therapy using docetaxel and trastuzumab in breast cancer
pp. 71-75(5)
Authors: Kurosumi, Masafumi; Tabei, Toshio; Sano, Muneaki; Honma, Kenichi; Yanagita, Yasuhiro; Yamamoto, Naohito; Inoue, Kenichi; Sato, Nobuaki; Kimura, Morihiko

Clinical significance of fibronectin expression in colorectal cancer
pp. 77-81(5)
Authors: Saito, Noboru; Nishimura, Hajime; Kameoka, Shingo

Akt- and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment
pp. 83-88(6)
Authors: Cho; Chae; Shin; Kim; Kim

Epigenetic mutations in CDKN2A in western Swedish families with hereditary malignant melanoma
pp. 89-91(3)
Authors: Erlandson; Appelqvist; Enerbäck

A single nucleotide polymorphism in exon 7 of sorbin and SH3-domain-containing-1 (SORBS1) in Korean PCOS patients
pp. 93-97(5)
Authors: Park, Jung-Mi; Gu, Bon-Hee; Lee, Eung-Ji; Kim, Jae-Young; Choi, Sung-Woo; Baek, Kwang-Hyun

c-Jun-mediated repression and transactivation of fibronectin
pp. 99-103(5)
Authors: Hayashi, Yukio; Shino, Yuji; Saito, Kengo; Tanzawa, Hideki; Shirasawa, Hiroshi

Genomic profiling of decreased DNA damage response in human squamous carcinoma cells
pp. 105-117(13)
Authors: Ku, Tony K.S.; Crowe, David L.

Prognostic implications of cimetidine on advanced serous ovarian carcinoma related to cyclooxygenase-2 expression
pp. 119-122(4)
Authors: Niwa, Kenji; Onogi, Kokyo; Wu, Yun; Mori, Hideki; Inoue, Yosuke; Tamaya, Teruhiko

HPV infection in Brazilian oral squamous cell carcinomapatients and its correlation with clinicopathological outcomes
pp. 123-129(7)
Authors: Oliveira; Ribeiro-Silva; Ramalho; Simões; Zucoloto

Progress of engineered antibody-targeted molecular imaging for solid tumors (Review)
pp. 131-134(4)
Authors: Zhao, Hong; Cui, Kemi; Muschenborn, Andrea; Wong, Stephen T.C.